Newsroom

Sorted by: Latest

-

Harmony Biosciences to Participate in Upcoming Investor Conferences

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences. Goldman Sachs 47th Annual Global Healthcare Conference Fireside Chat: June 9, 2026, at 8:40 a.m. ET Location: Miami, FL Oppenheimer CNS & Neuro-Muscular Summit Fireside Chat: June 10, 2026, at 3:25 p.m. ET Location: Miami, FL A webcast of the fireside chats will be available on the investor...
-

Stem Brings PowerTrack EMS to Latin America’s Utility-Scale Hybrid Market with Granja Solar Project in Chile

HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that Copec Flux, the renewable energy subsidiary of Copec S.A., is deploying Stem’s PowerTrack™ Energy Management System (EMS) at the Granja Solar project in Chile. This development expands Stem’s Latin America footprint and represents a meaningful step into the region’s utility-scale hybrid market. The Granja project is an existing 135 MW PV project that Copec is...
-

Intellicheck To Present at the Planet Microcap Showcase in Las Vegas

MELVILLE, N.Y.--(BUSINESS WIRE)--Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering proprietary on-demand digital and physical identity validation solutions, today announced that CEO Bryan Lewis will present at the Planet Microcap Showcase 2026 taking place on Wednesday, June 17, 2026 at the Bellagio Hotel & Resort in Las Vegas, Nevada. Joining him at the conference will be CFO Adam Sragovicz. The presentation will begin at 3:00 p.m. PT on Wednesday, June 17....
-

Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company focused on developing localized therapies for inflammatory and infectious skin diseases, today announced the publication of a peer-reviewed research article in the Journal of Dermatological Treatment evaluating the effects of its lead program, GX-03, in an IL-36–associated inflammatory environment. The publication, titled “Effects of extended-release topical polyhexanide in a...
-

Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference...
-

Futurum Group Enters Definitive Agreement to Acquire Aptiviti Inc., Parent of Enterprise Technology Research (ETR), Bringing Wall Street’s Premier Predictive Data into its Futurum Intelligence Platform™

AUSTIN, Texas--(BUSINESS WIRE)--The acquisition integrates Aptiviti’s ETR institutional-grade spending data into Futurum Intelligence Platform™ enhancing the range of intelligence...
-

Virchow Medical Strengthens Scientific Advisory Board with New Appointments

SAN DIEGO--(BUSINESS WIRE)--Virchow strengthens Scientific Advisory Board; appoints Mayo Clinic Laboratories CEO Dr. William Morice & Clinical Lab 2.0 Founder Khosrow Shotorban...
-

Eric Mosley, Founder and CEO of Workhuman, honoured with Visionary Leaders Award at Dublin Tech Summit

DUBLIN--(BUSINESS WIRE)--Eric Mosley, Founder and CEO of Workhuman, has been awarded the Visionary Leaders Award at this year’s Dublin Tech Summit, recognising his leadership in shaping the future of work through technology and human connection. Mosley was presented with the award at Dublin Tech Summit’s annual Leaders Dinner, where he was selected as one of two 2026 award recipients, with the evening spotlighting global tech leaders whose work continues to shape the future of business and tech...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 26.05.2026 GINC LN IE00BD842Y21 899,606.00 USD 57,963,650.20 64.432  ...
-

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

SAN DIEGO--(BUSINESS WIRE)--ClearNote Health announced the close of $52 million in Series D financing and appointment of Kevin Keegan as president and chief operating officer....